Clinical safety and effectiveness of indorenate in essential hypertension.
Huape-Arreola
Sandra
S
Medicine School Dr. Ignacio Chávez, UMSNH, General Hospital Dr. Miguel Silva, SSM, 58000 Morelia, Michoacán, México. Tzutzul@yahoo.com
Herrera-Abarca
J E
JE
Ruiz-Vega
Humberto
H
Hong
Enrique
E
D008735:5-Methoxytryptamine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011187:Posture / Q000502:physiology
D000959:Antihypertensive Agents; D008735:5-Methoxytryptamine; C033600:indorenate